Piramal Pharma Limited (NSE:PPLPHARMA)
India flag India · Delayed Price · Currency is INR
184.15
+4.30 (2.39%)
May 11, 2026, 3:30 PM IST

Piramal Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
238,814181,305297,962170,52881,683-
Market Cap Growth
-18.27%-39.15%74.73%108.77%--
Enterprise Value
282,006222,374341,742209,922130,128-
Last Close Price
179.85136.54224.60128.7266.76-
PE Ratio
--326.96956.95--
Forward PE
130.0882.5470.5442.3340.39-
PS Ratio
2.692.043.262.091.15-
PB Ratio
2.932.223.672.151.21-
P/TBV Ratio
5.944.5111.286.973.51-
P/FCF Ratio
31.3223.78130.7358.30--
P/OCF Ratio
14.4510.9733.3916.9816.88-
PEG Ratio
1.161.581.581.581.35-
EV/Sales Ratio
3.182.513.732.571.84-
EV/EBITDA Ratio
28.8125.4224.9218.4322.58-
EV/EBIT Ratio
191.09246.0454.0145.62--
EV/FCF Ratio
36.9829.16149.9471.77--
Debt / Equity Ratio
0.700.700.600.600.830.62
Debt / EBITDA Ratio
6.166.163.444.009.213.63
Debt / FCF Ratio
7.447.4421.3116.10--
Net Debt / Equity Ratio
0.530.530.550.530.740.57
Net Debt / EBITDA Ratio
4.944.943.243.688.703.47
Net Debt / FCF Ratio
5.665.6619.5214.34-10.43-31.27
Asset Turnover
0.530.530.590.550.520.57
Inventory Turnover
1.211.211.581.691.941.87
Quick Ratio
0.740.740.750.610.640.69
Current Ratio
1.511.511.541.251.261.34
Return on Equity (ROE)
-4.00%-4.00%1.14%0.24%-2.77%6.11%
Return on Assets (ROA)
0.34%0.34%2.55%1.93%-0.20%2.96%
Return on Invested Capital (ROIC)
0.73%0.72%1.13%0.38%-0.40%4.62%
Return on Capital Employed (ROCE)
0.70%0.70%5.30%4.20%-0.40%5.70%
Earnings Yield
-1.36%-1.80%0.31%0.10%-2.28%-
FCF Yield
3.19%4.21%0.77%1.71%-5.89%-
Dividend Yield
0.08%-0.06%0.08%--
Payout Ratio
--15.88%--13.30%
Buyback Yield / Dilution
0.43%0.43%-3.67%-7.85%-0.95%-87.83%
Total Shareholder Return
0.51%0.43%-3.61%-7.76%-0.95%-87.83%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.